ADMA Archives | GeoInvesting

January 22, 2019

ADMA New Catalysts For 2019 – Two PDUFA decisions on immunodeficiency therapies

This content is for members only

December 28, 2018

ADMA Biologics Believes It Can Resolve CRL Issues Quickly, Spring Review Possible

This content is for members only

December 20, 2018

ADMA Biologics Receives a Split FDA Decision on BIVIGAM

This content is for members only

December 13, 2018

ADMA Biologics (NASDAQ:ADMA) December Catalyst: PDUFA for BIVIGAM

This content is for members only